v3.25.2
Schedule of Share-based Compensation Expense (Details) - Sonnet BioTherapeutics Holdings, Inc. [Member] - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Share-based compensation $ 60,395 $ 60,395 $ 170,795 $ 231,190 $ 248,626
Restricted Stock Units (RSUs) [Member] | Research and Development Expense [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Share-based compensation 28,268 28,268 81,089 109,356 121,265
Restricted Stock Units (RSUs) [Member] | General and Administrative Expense [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Share-based compensation $ 32,127 $ 32,127 $ 89,706 $ 121,834 $ 127,361